Antineoplastics: Secondary haematological malignancies following breast cancer therapy: 6 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1083, 2006-01, pp. : 6-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antineoplastics: Secondary haematological malignancies: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1301, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Antineoplastics: Haematological toxicities: 7 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1413, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Antineoplastics/cetuximab: Skin rash and haematological toxicities: 11 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1362, 2011-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Antineoplastics: Secondary thyroid cancer (first report for bleomycin, cisplatin and dactinomycin) in patients with osteosarcoma: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1197, 2008-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Monoclonal Antibody Therapy in Haematological Malignancies

By  

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 148-159

Bentham Science Publishers

Access to resources Recommend Favorite